Women with stage 1 HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were unlikely to suffer cancer recurrence within 3 years of treatment.
Stereotactic body radiation therapy (SBRT) plus chemotherapy improves survival among patients with stage 4 lung cancerJanuary 20, 2015
Combining stereotactic body radiation therapy (SBRT) with a specific chemotherapy regimen more than doubled survival rates for certain patients with stage 4 lung cancer, according to recent research data.
A combination treatment with of the drug ramucirumab and FOLFIRI chemotherapy provides a survival advantage over standard treatment with FOLFIRI alone for patients with advanced colorectal cancer, according to study data.
Long-term outcomes improved by combining bevacizumab with newer chemotherapy regimen for advanced colorectal cancerJanuary 19, 2015
A phase III study of patients with metastatic colorectal cancer has indicated that FOLFOXIRI chemotherapy, in combination with bevacizumab, is superior to the standard FOLFIRI chemotherapy with bevacizumab.
Therapy dogs improve the emotional well-being of some patients with cancer who are undergoing concomitant chemotherapy and radiotherapy.
Use of the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation among patients with lymphoma undergoing a certain type of chemotherapy.
Investigators have identified two compounds that appear to block the cardiac damage caused by doxorubicin. Their report indicates that inhibiting the action of an enzyme key to the generation of cellular energy in mitochondria could prevent doxorubicin-induced damage to cardiac cells without reducing the drug's antitumor effects.
In what sequence should you administer premedications prior to paclitaxel: Should the antihistamine be given first or the steroid?
Pictilisib and pembrolizumab may prolong survival for women with advanced breast cancer, according to data from preliminary studies.
Per a new study, resistant exercise decreased physical fatigue and maintained quality of life among patients with breast cancer receiving adjuvant chemotherapy.
A drug typically used to treat infection of the retina in people with AIDS has been shown, for the first time, to sensitize cervical cancer to both chemotherapy and radiotherapy.
10 most asked about complementary medicines all may result in drug interactions with administered with chemotherapy, radiation, or prior to surgery.
Pancreatic cancer may potentially be safely and effectively treated with immunochemotherapy, according to recent research from a preclinical study.
A chemotherapy regimen of procarbazine, lomustine (CCNU), and vincristine (PCV) administered after radiation therapy improved both progression-free survival and overall survival in adults with low-grade gliomas.
A new project is working on improving scalp cooling technology that prevents hair loss in cancer patients.
Findings show benefits compared with FOLFIRI for patients with untreated metastatic disease.
A new technique to treat retinoblastoma may help prevent eye loss, blindness, or death in children with advanced forms of the disease.
Herceptin in addition to chemotherapy boosts survival, reduces risk of cancer recurrence
Recommended safe handling practices for workers who administer antineoplastic drugs in health care settings are not always followed, according to a new study.
Legislation passed in 2003 intended to slow the spiraling costs of drugs paid for by the federal government to treat Medicare patients has not proved to be a success.
The first direct comparison of treating nonsquamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival.
Is sequencing important when administering chemotherapy on the same day?
Treatnent with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to phase II trial data.
Addition of the experimental drug cediranib to standard chemotherapy improves tumor shrinkage and adds a modest improvement in progression-free survival for patients with cervical cancer that has recurred after treatment.
After failure of platinum-based chemotherapy, the tyrosine kinase inhibitor (TKI) afatinib significantly improved progression-free survival in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
International team assessed the impact of cancer treatment on children of women pregnant at diagnosis or during treatmentOctober 15, 2014
A number of oncologists hesitate to administer treatments to pregnant patients with cancer, due to concerns about the effect on the unborn.
Akynzeo approved for the treatment chemotherapy-induced nausea and vomiting (CINV) in patients with cancer.
Can vitamins or supplements help address hair loss caused by cancer therapy?
Nivolumab shows signs of superior response rate compared with standard chemotherapy in advanced melanomaOctober 10, 2014
The monoclonal antibody nivolumab has demonstrated superior response and duration over standard chemotherapy in patients whose melanoma has progressed after ipilimumab treatment.
For younger patients with an acute lymphoblastic leukemia (ALL) subtype, modifying treatment based on chemotherapy response can make a vital difference.
- E-cigarettes declared a health threat by California health officials
- Study makes a case for wider gene testing in patients with colorectal cancer
- New study helps physicians and patients determine prostate cancer risk
- Effectiveness of nanoparticle drugs was hindered by tumor microenvironment in triple-negative breast cancer
- Existing drug extends survival for patients with rare thymic carcinoma
- Oncology patient navigation: Bringing this crucial role to the forefront
- Radiation plus hormone therapy prolongs survival for older men with prostate cancer
- Mistletoe: The holiday plant is making headlines as an alternative cancer treatment
- Using genomic correlates of radiotoxicity to predict patient outcomes
- Therapy dogs may encourage cancer patient to persevere with treatment
- Research promising for reducing risk of breast cancer spreading to the brain
- Biopsies with DCIS diagnosis increase for women undergoing mammography
- Fear of cancer may have unwanted effect on public screening uptake
- PDE-5 inhibitors increase risk of biochemical recurrence after radical prostatectomy
- Many breast cancer patients lack basic knowledge about their disease
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|